Cargando…
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
Reversing or slowing the aging process brings great promise to treat or prevent age‐related disease, and targeting the hallmarks of aging is a strategy to achieve this. Epigenetics affects several if not all of the hallmarks of aging and has therefore emerged as a central target for intervention. On...
Autores principales: | McIntyre, Rebecca L, Daniels, Eileen G, Molenaars, Marte, Houtkooper, Riekelt H, Janssens, Georges E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728603/ https://www.ncbi.nlm.nih.gov/pubmed/31368626 http://dx.doi.org/10.15252/emmm.201809854 |
Ejemplares similares
-
Integrating the Hallmarks of Aging Throughout the Tree of Life: A Focus on Mitochondrial Dysfunction
por: van der Rijt, Sanne, et al.
Publicado: (2020) -
Biological Age Prediction From Wearable Device Movement Data Identifies Nutritional and Pharmacological Interventions for Healthy Aging
por: McIntyre, Rebecca L., et al.
Publicado: (2021) -
Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion
por: Liu, Yasmine J., et al.
Publicado: (2019) -
Mitochondrial ubiquinone–mediated longevity is marked by reduced cytoplasmic mRNA translation
por: Molenaars, Marte, et al.
Publicado: (2018) -
Inhibition of the neuromuscular acetylcholine receptor with atracurium activates FOXO/DAF‐16‐induced longevity
por: McIntyre, Rebecca L., et al.
Publicado: (2021)